Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Type I interferons play a key role in the development of various skin diseases.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Hair loss in black women needs more research, early intervention, and community education.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Certain molecules in hair change with age and could be used for cosmetic treatments.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Hair and nails are similar keratin structures with different shapes and growth, affected by the same diseases and environmental factors.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Lupus can cause hair loss and nail changes, with treatments available for both.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.